Arsenal Bio Patents

Patent portfolio assigned to Arsenal Bio (verified via public assignee records). Programmable CAR-T / cell-therapy biotech (Arsenal Biosciences, South San Francisco). Bristol Myers Squibb confirmed via ArsenalBio's own press as a paying multi-program collaboration (milestones + royalties); Regeneron named as investor/partner in financing press. Google Patents assignee search confirms patents assigned to Arsenal Biosciences Inc (e.g. WO2025199346A1, AU2021369494A1). Competitors per Growjo listing.